Table 2 Univariable regression analysis for cf-PWV
Variables | Coefficient estimate (95% CI) | p-value |
|---|---|---|
Time | −0.52 (−1.06; 0.02) | 0.057 |
Age | 0.11 (0.04; 0.02) | 0.002 |
BMI | 0.01 (−0.14; 0.17) | 0.899 |
Smoking | −0.47 (−2.05; 1.11) | 0.561 |
ESS | 0.13 (0.04; 0.23) | 0.004 |
ESS >10 | −0.15 (−1.47; 1.17) | 0.822 |
AHI (events/h) | 0.01 (−0.03; 0.04) | 0.725 |
ODI (events/h) | 0.01 (−0.03; 0.04) | 0.705 |
Mean SaO2 (%) | −0.06 (−0.37; 0.26) | 0.730 |
Lower SaO2 (%) | 0.04 (−0.04; 0.11) | 0.366 |
SaO2 < 90% (%) | −0.002 (−0.04; 0.03) | 0.917 |
CPAP compliance | −0.09 (−0.67; 0.48) | 0.752 |
Total cholesterol, mg/dl | −0.002 (−0.02; 0.02) | 0.794 |
HDL-cholesterol, mg/dl | −0.05 (−0.10; 0.01) | 0.127 |
LDL-cholesterol, mg/dl | −0.01 (−0.03; 0.01) | 0.554 |
Triglycerides, mg/dl | 0.01 (−0.00; 0.02) | 0.168 |
Glucose, mg/dl | 0.02 (−0.01; 0.05) | 0.229 |
HbA1c, % | 0.41 (−0.076; 1.59) | 0.490 |
24 h SBP (mm Hg) | 0.09 (0.04; 0.14) | <0.001 |
24 h DBP (mm Hg) | 0.05 (−0.01; 0.12) | 0.109 |
Pulse pressure (mm Hg) | 0.15 (0.08; 0.21) | <0.001 |
24 h MBP (mm Hg) | 0.04 (−0.02; 0.10) | 0.224 |
Day-time SBP (mm Hg) | 0.09 (0.04; 0.13) | <0.001 |
Day-time DBP (mm Hg) | 0.04 (0.02; 0.11) | 0.167 |
Night-time SBP (mm Hg) | 0.07 (0.03; 0.11) | 0.002 |
Night-time DBP (mm Hg) | 0.05 (−0.01; 0.11) | 0.109 |
Hypertension | 1.29 (−0.24; 2.81) | 0.099 |
Antihypertensive drugs | 1.37 (0.13; 2.61) | 0.030 |
Dyslipidaemia | 0.49 (−1.19; 2.17) | 0.569 |
Lipid lowering drugs | 0.22 (−1.09; 1.52) | 0.745 |
MetS | 1.44 (0.18; 2.70) | 0.025 |